A praxeological approach to the goings-on in Exeter, NH.
Sunday, September 4, 2016
EpiPen price is NOT a market price
Not one word in this article about the real culprit of high EpiPen prices (and drug prices in general): the FDA, which Mylan lobbies for monopolistic privileges to exclude other competitors. This is crony corporatism, courtesy of Uncle Sam.
No comments:
Post a Comment